Cogent Biosciences, Inc.

COGT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEF 14A Apr 23, 2026 DEF 14A
4 Apr 3, 2026 4
144 Mar 31, 2026
4 Mar 31, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Mar 31, 2026
SCHEDULE 13G/A Mar 26, 2026
SCHEDULE 13G/A Feb 17, 2026
S-8 Feb 17, 2026 S-8
SCHEDULE 13G/A Feb 17, 2026
10-K Feb 17, 2026 10-K
8-K Feb 17, 2026 8-K
SCHEDULE 13G/A Jan 30, 2026
4 Jan 22, 2026 OWNERSHIP DOCUMENT
144 Jan 22, 2026
SCHEDULE 13D/A Jan 22, 2026
SCHEDULE 13G/A Jan 21, 2026
SCHEDULE 13G/A Jan 21, 2026
4 Jan 5, 2026 4
4 Dec 30, 2025 4
4 Dec 30, 2025 4
4 Dec 30, 2025 4
4 Dec 30, 2025 4
144 Dec 29, 2025
144 Dec 29, 2025
144 Dec 29, 2025
← Newer Page 2 of 25 · 614 filings Older →